World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
35680
World Ranking
7414
National Ranking
3875

Overview

Judd W. Moul is affiliated with Duke University in the United States and has contributed extensively to medical research, particularly focusing on oncology and prostate cancer. Their body of work includes more than one hundred publications primarily within the field of medicine.

The scientist's research spans several subfields, prominently including pulmonary and respiratory medicine, oncology, cancer research, surgery, and economics and econometrics. These diverse interests underscore a multidisciplinary approach to medical science.

The main topics addressed in their work include prostate cancer diagnosis and treatment, prostate cancer treatment and research, cancer related to lipids and metabolism, intensive care unit cognitive disorders, cardiac anesthesia and surgical outcomes, anesthesia and neurotoxicity research, and lymphoma diagnosis and treatment.

Judd W. Moul has published in several notable venues throughout their career. The most frequent publication venues are:

  • ONCOLOGY
  • The Journal of Urology
  • Prostate Cancer and Prostatic Diseases
  • Urology
  • Urology Practice

The scientist often collaborates with other researchers, including frequent coauthors such as Neck Cancer, Howard S. Höchster, New Brunswick, William J. Gradishar, and Tari A. King, reflecting a collaborative research environment.

Selected recent papers exemplify the range and focus of their research:

  • Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification, 2023, published in Prostate Cancer and Prostatic Diseases
  • A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2), 2020, Clinical Cancer Research
  • Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers, 2022, Annals of Clinical and Translational Neurology
  • Current Frontline Treatment of Diffuse Large B-Cell Lymphoma, 2022, ONCOLOGY
  • A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults, 2020, Journal of Neurology

Best Publications

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

    Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino

  • Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men

    Ted O. Morgan;Steven J. Jacobsen;William F. McCarthy;Debra J. Jacobson

  • Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy

    Anthony V. D’Amico;Judd W. Moul;Peter R. Carroll;Leon Sun

  • Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

    Anthony V. D’Amico;Judd Moul;Peter R. Carroll;Leon Sun

  • Frequent Detection of Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancers

    Jaya P. Gaddipati;David G. McLeod;Howard B. Heidenberg;Isabell A. Sesterhenn

  • Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

    Susan Halabi;Chen-Yen Lin;W. Kevin Kelly;Karim S. Fizazi

  • Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

    Christopher L. Amling;Robert H. Riffenburgh;Leon Sun;Judd W. Moul

  • Prostate specific antigen only progression of prostate cancer

    Judd W. Moul

  • Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

    Gyorgy Petrovics;Aijun Liu;Syed Shaheduzzaman;Bungo Furasato

  • PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

    Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu

  • Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

    Lionel L. Bañez;Robert J. Hamilton;Robert J. Hamilton;Alan W. Partin;Robin T. Vollmer

  • The Changing Face of Prostate Cancer

    Matthew R. Cooperberg;Judd W. Moul;Peter R. Carroll

  • Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility

    O. John Semmes;Ziding Feng;Bao Ling Adam;Lionel L. Banez

  • p53 regulates the expression of the tumor suppressor gene maspin.

    Zhiqiang Zou;Chunling Gao;Akhilesh K. Nagaich;Theresa Connell

  • Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy

    Florian R. Schroeck;Tracey L. Krupski;Leon Sun;David M. Albala

  • Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy

    Jason C. Massengill;Leon Sun;Judd W. Moul;Hongyu Wu

  • Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men

    Judd W. Moul;Isabell A. Sesterhenn;Roger R. Connelly;Thomas Douglas

  • Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results.

    David F. Paulson;Judd W. Moul;Philip J. Walther

  • Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

    Judd W. Moul;Judd W. Moul;Hongyu Wu;Leon Sun;David G. McLEOD

Frequent Co-Authors

David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Thomas J. Polascik
Thomas J. Polascik Duke University
Isabell A. Sesterhenn
Isabell A. Sesterhenn United States Army Research Laboratory
Shiv Srivastava
Shiv Srivastava Uniformed Services University of the Health Sciences
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center
Christopher J. Kane
Christopher J. Kane University of California, San Diego
Anthony V. D'Amico
Anthony V. D'Amico Brigham and Women's Hospital
Leah Gerber
Leah Gerber Duke University
E. David Crawford
E. David Crawford University of California, San Diego
Ming-Hui Chen
Ming-Hui Chen University of Connecticut

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a physician. There are several online degree options and flexible career pathways that support healthcare delivery and management. For registered nurses looking to advance, adn to np bridge programs offer a convenient route to become nurse practitioners through online learning.

If nutrition science interests you, earning an online nutrition degree can open doors in clinical, community, and wellness settings. For those with leadership ambitions, cahme accredited online healthcare administration programs prepare graduates for vital roles in healthcare management and policy, with the advantage of accredited online learning.

Nurses considering a bachelor’s degree can explore if their chosen does rn to bsn require clinicals—some RN to BSN programs have reduced or no clinical requirements, making them flexible for working professionals. These options offer pathways to healthcare careers beyond traditional medical schooling, supporting students with diverse goals in the industry.

Best Scientists Citing Judd W. Moul

Trending Scientists

Recently Published Articles